
Privacy & Data Protection Policy
Commitment of Takumi Pharmaceutical Manufacturing Companies to personal information protection, pharmacovigilance safety reporting, and regulatory confidentiality.
1. Fundamental Policy on Personal Information
Takumi Pharmaceutical Manufacturing Companies (“Takumi”, “we”, or “our”) complies with Japan's Act on the Protection of Personal Information (APPI), Pharmaceuticals and Medical Devices Agency (PMDA) regulatory guidelines, and all applicable privacy standards. We treat all personal data acquired from patients, healthcare professionals, business partners, and shareholders with the utmost integrity and strict security controls.
2. Purpose of Collection and Processing
Personal data collected through this website and our medical affairs divisions is used exclusively for:
- Providing clinical package inserts, bioequivalence datasets, and pharmaceutical safety information to medical professionals.
- Executing mandatory pharmacovigilance investigations and reporting adverse drug reactions to the PMDA and Ministry of Health, Labour and Welfare (MHLW).
- Responding to inquiries from hospital formularies, community pharmacies, and distribution partners.
- Managing corporate governance and shareholder disclosures in compliance with Tokyo Stock Exchange regulations.
3. Security Management Measures
We implement technical, physical, and organizational security controls to protect personal data against unauthorized access, leakage, destruction, or falsification. Access to pharmacovigilance databases is restricted to authorized medical affairs personnel under non-disclosure protocols.
4. Contact for Privacy Inquiries
For requests regarding data disclosure, correction, deletion, or questions concerning our personal information management policies, please contact our Compliance Office:
Takumi Pharmaceutical Manufacturing Companies
Yodogawa-ku, Osaka 532-0003, Japan
Direct Inquiries via Contact Form →
